Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
Select bar for recommendation details.
Recommendations | 14-Nov-24 | |
---|---|---|
Buy | 4 | |
Outperform | 3 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 2 analysts offering 12 month price targets for MaxCyte Inc have a median target of 638.65, with a high estimate of 772.89 and a low estimate of 504.41. The median estimate represents a 140.09% increase from the last price of 266.00.
High | 190.6% | 772.89 |
Med | 140.1% | 638.65 |
Low | 89.6% | 504.41 |
Earnings history & estimates in USD
Average growth rate | -16.96% |
More ▼
Revenue history & estimates in USD
Average growth rate | +18.61% |
More ▼